Researchers should take note of the two following risk factors: Impure epithalon Epithalon has not been approved outside of Russia, pending further study
doi: 10.1016/j.freeradbiomed.2005.03.022
United States Patent Application US20160030502 (A1) Schmacht M, Lorenz E, Stahl U, Senz M (2015) Glutathione overproduction in high cell density continuous cultivation of Saccharomyces spp., 28th International VH-Yeast Conference, Berlin, Germany Schmacht M, Lorenz E, Stahl U, Senz M (2017) Medium optimization based on yeasts elemental composition for glutathione production in Saccharomyces cerevisiae
No pharmaceutical companies are going to sign up for that, because even if they make it all the way to approval, why would anyone buy it from them if they can already get it from China? What are the side effects of peptides
In the case of tracking applications, cells must also be labeled with these MRI contrast agents